Skip to main content

Table 3 DA, DV, and BFV of AVF in six-time points (\(\overline{x}\) ± SD)

From: A clinical randomized controlled trial: moxibustion at Laogong interval with Panax notoginseng promoted the maturation of arteriovenous fistulae

   MLPN group (n = 37) Control group (n = 37) t P
T0 DA, mm 2.59 ± 0.99 2.51 ± 0.76 0.425 0.672
DV, mm 2.69 ± 0.79 2.76 ± 0.86 0.387 0.700
T1 DA, mm 3.60 ± 0.96*** 3.41 ± 0.76*** 0.912 0.375
DV, mm 4.12 ± 0.98*** 3.59 ± 0.89*** 2.463 0.016
BFV, ml/min 771.9 ± 374.42 571.51 ± 305.38 2.503 0.015
T2 DA, mm 3.97 ± 0.96*** 3.91 ± 0.88*** 0.266 0.791
DV, mm 4.44 ± 0.82*** 3.99 ± 1.22*** 1.831 0.071
BFV, ml/min 935.49 ± 444.01 752.97 ± 395.38# 1.867 0.066
T3 DA, mm 4.26 ± 1.03*** 4.08 ± 0.94*** 0.776 0.440
DV, mm 4.86 ± 1.00*** 4.37 ± 1.28*** 1.849 0.069
BFV, ml/min 996.30 ± 456.86# 811.72 ± 424.29## 1.801 0.076
T4 DA, mm 4.65 ± 1.03*** 4.23 ± 1.00*** 1.780 0.079
DV, mm 5.03 ± 1.07*** 4.70 ± 1.47*** 1.138 0.259
BFV, ml/min 1183.87 ± 739.26## 864 ± 467.01## 2.232 0.029
T5 DA, mm 4.72 ± 1.26*** 5.07 ± 1.14*** 0.370 0.712
DV, mm 5.13 ± 1.08*** 4.90 ± 1.51*** 0.706 0.483
BFV, ml/min 1078.10 ± 590.04## 957.75 ± 648.43## 0.780 0.438
  1. ***Significant different compared to T0 (P < 0.001)
  2. # Significant different compared to T1 (P < 0.05), ##Significant different compared to T1 (P < 0.01)
  3. AVF: arteriovenous fistula; MLPN: moxibustion at Laogong interval with Panax notoginseng; DA: diameter of anastomosis; DV: diameter of draining veins; BFV: blood flow of draining veins